Li Ge

This profile gathers the share dealings of Li Ge across 2 companies, led by WuXi Biologics (Cayman) Inc. and WuXi AppTec Co., Ltd. - H Shares. We count 290 filings; the first trade dates from 14 December 2017 and the latest from 13 October 2026.

The open-market side counts 6 purchases for €22.7M alongside 158 sales for €11.2B. The totals do not cover 4 filings with an undisclosed amount. Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay. Since January 2026: 1 purchase and 7 sales on the market.

Half of the purchases are above €1.4M and half below. 1 out of 6 purchases came within 30 days of a purchase by at least one other insider of the same company. A cluster is several different insiders buying the same stock within a short window, a pattern studied more closely than a single purchase. After 5 purchases with a full 90-day history, the hit rate stands at 60% and the median 90-day move at +5.4%. This is a record of the past, not a forecast.

On 20 October 2026 came the latest disclosure, an open-market sale for €537.0M in WuXi Biologics (Cayman) Inc. The most recent open-market purchase was published on 17 June 2026, 131 days ago. Between a trade and the moment it shows up on HKEX, the median delay is 3 days. That lag is the time during which only the insider knows about the trade. Keep in mind that insiders sell for many reasons unrelated to the outlook, from tax bills to estate planning. Every figure here comes from the filings published by HKEX and describes the past, not future prices; it is not investment advice.